A
Amit Huppert
Researcher at Sheba Medical Center
Publications - 90
Citations - 6002
Amit Huppert is an academic researcher from Sheba Medical Center. The author has contributed to research in topics: Population & Medicine. The author has an hindex of 27, co-authored 75 publications receiving 3103 citations. Previous affiliations of Amit Huppert include Tel Aviv University & Technion – Israel Institute of Technology.
Papers
More filters
Journal ArticleDOI
Complex dynamics and phase synchronization in spatially extended ecological systems
TL;DR: This work examines the synchronization of complex population oscillations in networks of model communities and in natural systems, where phenomena such as unusual ‘4- and 10-year cycle’ of wildlife are often found.
Journal ArticleDOI
Protection of BNT162b2 Vaccine Booster against Covid-19 in Israel.
Yinon M. Bar-On,Yair Goldberg,Micha Mandel,Omri Bodenheimer,Laurence Freedman,Nir Kalkstein,Barak Mizrahi,Sharon Alroy-Preis,Nachman Ash,Ron Milo,Amit Huppert +10 more
TL;DR: In this paper, the authors investigated the effect of the booster dose on the rate of confirmed coronavirus 2019 disease (Covid-19) and the rates of severe illness.
Journal ArticleDOI
Duration of effectiveness of vaccines against SARS-CoV-2 infection and COVID-19 disease: results of a systematic review and meta-regression
Daniel R. Feikin,Melissa M. Higdon,Laith J. Abu-Raddad,Nick Andrews,Rafael Araos,Yair Goldberg,Michelle J. Groome,Amit Huppert,Katherine L. O’Brien,Pete Smith,Annelies Wilder-Smith,Scott L. Zeger,Maria Deloria Knoll,Minal Patel +13 more
TL;DR: COVID-19 vaccine efficacy or effectiveness against severe disease remained high, although it did decrease somewhat by 6 months after full vaccination, and the decrease is likely caused by, at least in part, waning immunity.
Journal ArticleDOI
Seasonal dynamics of recurrent epidemics
TL;DR: Despite the mathematical intractability of the forced SIR model, a new threshold effect is identified and given clear analytical conditions for predicting the occurrence of either a future epidemic outbreak, or a ‘skip’—a year in which an epidemic fails to initiate.
Journal ArticleDOI
Evidence for increased breakthrough rates of SARS-CoV-2 variants of concern in BNT162b2-mRNA-vaccinated individuals.
Talia Kustin,Noam Harel,Uriah Finkel,Shay Perchik,Sheri Harari,Maayan Tahor,Itamar Caspi,Rachel Levy,Michael Leshchinsky,Shifra Ken Dror,Galit Bergerzon,Hala Gadban,Faten Gadban,Eti Eliassian,Orit Shimron,Loulou Saleh,Haim Ben-Zvi,Elena Keren Taraday,Doron Amichay,Doron Amichay,Anat Ben-Dor,Dana Sagas,Merav Strauss,Yonat Shemer Avni,Amit Huppert,Amit Huppert,Eldad Kepten,Ran D. Balicer,Doron Netzer,Shay Ben-Shachar,Shay Ben-Shachar,Adi Stern +31 more
TL;DR: In this paper, a matched cohort study was conducted to examine the distribution of VOCs in infections of BNT162b2 mRNA vaccinees from Clalit Health Services (Israel) using viral genomic sequencing, and hypothesized that if vaccine effectiveness against a VOC is reduced, its proportion among breakthrough cases would be higher than in unvaccinated controls.